Immunoblotting analysis confirmed that Srx and Prxs protein expression was upregulated in CD133+ CSCs isolated from the HT29, HCT116, and SNUC5 colon cancer cell lines (Fig. 2C). The gene discussed is SRXN1; the disease is malignant colon neoplasm.